BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2129309)

  • 1. [Branhamella catarrhalis respiratory tract infections].
    Letonja S; Music E; Kumelj M
    Plucne Bolesti; 1990; 42(3-4):144-7. PubMed ID: 2129309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
    Texier-Maugein J; Escoubas J; Fouche J; Mormede M
    Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Respiratory infections caused by Branhamella catarrhalis in 5 different hospitals].
    Matsumoto K; Nakayama T; Rikitomi N; Yoshida T; Oishi K; Takahashi A; Tanaka H; Suzuki H; Nagatake T; Ide M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Mar; 28(3):448-56. PubMed ID: 2120497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A; Janicka G; Krawiecka D; Kochanowska J
    Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Occurrence of Moraxella catarrhalis in patients with respiratory tract infections].
    Jakubicz P; Leszczyńska K
    Med Dosw Mikrobiol; 1997; 49(1-2):55-60. PubMed ID: 9411073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory tract infections due to Branhamella catarrhalis and Neisseria species.
    McGowan JE
    Curr Clin Top Infect Dis; 1987; 8():181-203. PubMed ID: 3151758
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of Moraxella catarrhalis infections of the lower respiratory tract in elderly patients.
    Tamang MD; Dey S; Makaju RK; Jha BK; Shivananda PG; Bhramadatan KN
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):39-44. PubMed ID: 16401943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation of Branhamella catarrhalis from sputum and clinical features of bronchopulmonary infection due to Branhamella catarrhalis].
    Kinoshita A; Mukae H; Takase T; Ishino T; Kohno S; Kanda T; Yamaguchi K; Hirota M; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jun; 28(6):875-81. PubMed ID: 2120499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of Moraxella catarrhalis in patients at King Khalid University Hospital, Riyadh.
    Babay HA
    Saudi Med J; 2000 Sep; 21(9):860-3. PubMed ID: 11376364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
    Prado V; Giangrieco M; Durán C; Ojeda A; van Flaskamp R
    Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Branhamella catarrhalis in respiratory infections].
    Marín Casanova P; García-Martos P; Fernández Fatou B; Bernal García F; Agudo Pérez E
    Rev Clin Esp; 1989 May; 184(8):399-400. PubMed ID: 2506614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of 3 fluoroquinolones on Branhamella catarrhalis].
    Suermondt G; Denamur E; Laurans G; Orfila J
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):647-50. PubMed ID: 3141885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections].
    Bourgeois F; Lambert-Zechovsky N; Bingen E
    Pathol Biol (Paris); 1993 Jun; 41(6):555-61. PubMed ID: 8247636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Respiratory tract infections: how frequent is antibiotic resistance? In vitro activity of older and recent antibiotics against the significant pathogens].
    Ruckdeschel G
    Fortschr Med; 1994 Nov; 112(33):485-8. PubMed ID: 7843673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E; Dalhoff A; Korfmann G
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Branhamella catarrhalis: its respiratory pathogenicity in childhood].
    Moreno Galdo A; Ferrer Marcelles A; Aizpurúa Galdeano P; Navarro Aguirre M; Fernández Pérez F; Iglesias Berengue J
    An Esp Pediatr; 1990 Aug; 33(2):135-9. PubMed ID: 2125809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance, isolation, identification and sensitivity of Branhaemella (moraxella) catarrhalis.
    Hafiz S; Hafiz T; Yazdani I
    J Pak Med Assoc; 1993 Aug; 43(8):153-4. PubMed ID: 8264093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branhamella catarrhalis: an unappreciated pulmonary pathogen.
    Roth RM; Gleckman RA; Hibert DM
    Am Fam Physician; 1984 Oct; 30(4):169-73. PubMed ID: 6333806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.